Targeting immune cells for cancer therapy

Targeting immune cells for cancer therapy

10.1016/j.redox.2019.101174

Saved in:

書目詳細資料
Main Authors:	Gun, S.Y., Lee, S.W.L., Sieow, J.L., Wong, S.C.
其他作者:	MICROBIOLOGY AND IMMUNOLOGY
格式:	Review
出版:	Elsevier B.V. 2021
主題:	Cancer Immune checkpoint Immunotherapy Inflammation Nanoparticles
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/209959
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	National University of Singapore

相似書籍

Targeting immune cells for cancer therapy
由: Gun, Sin Yee, et al.
出版: (2020)

The role of immunotherapy in the treatment of advanced cervical cancer: Current status and future perspectives
由: Walsh, RJ, et al.
出版: (2021)

IMMUNOTHERAPY AGAINST ADVANCED CANCERS – CHIMERIC ANTIGEN RECEPTOR-BASED APPROACH AND IMMUNE CHECKPOINT REGULATION
由: TAY CHIN KANG JOHAN
出版: (2019)

B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion
由: Luu, Khang, et al.
出版: (2022)

Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
由: Sundar, R., et al.
出版: (2021)

Transformable nanosensitizer with tumor microenvironment-activated sonodynamic process and calcium release for enhanced cancer immunotherapy
由: Tan, Xuan, et al.
出版: (2022)

An inhibitory role for human CD96 endodomain in T Cell anti-tumor responses
由: Wang, Chelsia Qiuxia, et al.
出版: (2023)

Microbial synthesis of Prussian blue for potentiating checkpoint blockade immunotherapy
由: Wang, Dongdong, et al.
出版: (2023)

Checkpoint nano-PROTACs for activatable cancer photo-immunotherapy
由: Zhang, Chi, et al.
出版: (2023)

IMMUNOREGULATORY PROPERTIES OF CD137-CD137 LIGAND AXIS IN TUMOURS AND CHRONIC INFLAMMATORY CONDITIONS
由: LUU NGUYEN KHANG
出版: (2022)

Obstacles for T-lymphocytes in the tumour microenvironment: therapeutic challenges, advances and opportunities beyond immune checkpoint
由: Verma, Navin Kumar, et al.
出版: (2023)

Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
由: Sundar, R, et al.
出版: (2019)

CYTOKINE-ACTIVATED γδ T CELLS IN ADOPTIVE IMMUNOTHERAPY
由: TEO HUEY YEE
出版: (2023)

Multi-functional nanoparticles for cancer therapy
由: Chatterjee, D.K., et al.
出版: (2014)

Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer
由: Ngoi, NYL, et al.
出版: (2021)

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature
由: Tay, Sen Hee, et al.
出版: (2022)

Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy
由: Li, J., et al.
出版: (2021)

Immune checkpoint inhibitors in ovarian cancer: where do we stand?
由: Leary, A, et al.
出版: (2021)

Polarization of tumor-associated macrophages promoted by vitamin C-loaded liposomes for cancer immunotherapy
由: Ma, Zhaoyu, et al.
出版: (2023)

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application
由: Huo, Jin-Ling, et al.
出版: (2022)

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
由: Ng K.Y.Y., et al.
出版: (2022)

Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
由: Huang, Yiqing, et al.
出版: (2022)

STEM CELL- AND DENDRITIC CELL-BASED CANCER IMMUNOTHERAPY TARGETING CANCER STEM CELLS
由: CHEN CAN
出版: (2015)

SILENCING XRN1 ENHANCED THE EFFECT OF IMMUNE CHECKPOINT BLOCKADE THERAPY
由: RAN XUEBIN
出版: (2022)

IPSC-DERIVED IMMUNE CELLS FOR CANCER IMMUNOTHERAPY
由: TANG SHIN YI
出版: (2018)

Innovative evolution of cancer gene and cellular therapies
由: Lam, P., et al.
出版: (2014)

Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
由: Nguyen, Phuong H. D., et al.
出版: (2023)

Activatable polymer nanoenzymes for photodynamic immunometabolic cancer therapy
由: Zeng, Ziling, et al.
出版: (2022)

Immunotherapy targeting isoDGR-protein damage extends lifespan in a mouse model of protein deamidation
由: Kalailingam, Pazhanichamy, et al.
出版: (2024)

EVALUATION OF NOVEL ANTIBODIES FOR CHIMERIC ANTIGEN RECEPTOR T CELL APPLICATIONS
由: LEONARD WEN YAN LEONG
出版: (2021)

ENGINEERING PROBIOTICS TO MODULATE IMMUNE RESPONSES AGAINST BLADDER CARCINOMA
由: SIEOW FU-LONG BRENDAN
出版: (2023)

ENGINEERING PROBIOTICS TO MODULATE IMMUNE RESPONSES AGAINST BLADDER CARCINOMA
由: SIEOW FU-LONG, BRENDAN
出版: (2023)

AIM2 INFLAMMASOME ACTIVATION IN TUMOR ASSOCIATED MACROPHAGES AND ITS IMPACT ON CANCER DEVELOPMENT
由: CHEW ZHI HUAN
出版: (2019)

Epithelial to mesenchymal transition regulates surface pd-l1 via cmtm6 and cmtm7 induction in breast cancer
由: Xiao, Malina, et al.
出版: (2022)

Immunotherapy targeting isoDGR-protein damage extends lifespan in a mouse model of protein deamidation
由: Kalailingam, Pazhanichamy, et al.
出版: (2024)

Targeting tumours by adoptive transfer of immune cells
由: MacAry, P.A., et al.
出版: (2011)

A semiconducting iron-chelating nano-immunomodulator for specific and sensitized sono-metallo-immunotherapy of cancer
由: He, Shasha, et al.
出版: (2023)

Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapy
由: Yu, Jie, et al.
出版: (2025)

Mechanisms and functions of lymphangiogenesis in regulating the immune response and inflammation resolution
由: TAN KAR WAI
出版: (2012)

Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
由: Goggi, Julian L., et al.
出版: (2022)